HET EUROPEES GENEESMIDDELENAGENTSCHAP GEEFT GOEDKEURING VOOR HET AANVRAGEN VAN EEN VERGUNNING VOOR FILGOTINIB VOOR DE BEHANDELING VAN COLITIS ULCEROSA

NEXT STORY
Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11
PREV STORY
Inventiva announces the publication of a scientific paper on the role of PPARs in the treatment of NASH in the medical journal Nature Review Gastroenterology & Hepatology
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OXiGENE Announces Results of Phase 2 Study of CA4P in Recurrent Ovarian Cancer Published in Journal of Clinical Oncology

Study met primary endpoint of improvement in progression free survival Preliminary data show improvement in ...

author_avatar
NASDAQ Market News

Adverum Presents 2-Year OPTIC Data Demonstrating Sustained Durability and Promising Safety Profile from Single Intravitreal Injection of ADVM-022 in Wet AMD Patients Who Previously Required Frequent Anti-VEGF Injections

author_avatar
NASDAQ Market News

RAPT Therapeutics Appoints Rodney Young as Chief Financial Officer

author_avatar
NASDAQ Market News